Skip to main content

Nifty forms bearish candle on weekly charts, experts say avoid positional longs

Mazhar Mohammad of Chartviewindia.in advised traders to avoid positional longs but should consider shorting rallies on early signs of weakness.

The Nifty50 recouped some of the previous day's losses and remained higher for major part of the session on October 16 backed by positive European cues, and buying in banking & financials, metals and pharma stocks.

The index closed above 11,750 and formed small bodied bullish candle on the daily charts as closing was higher than opening levels, while there was a bearish candle formation on the weekly scale as it lost 1.3 percent for the week.

Experts feel 11,661 is expected to be a crucial level and if the index holds the same in coming days, then it can move towards 11,900 mark again.

For the time being, Mazhar Mohammad of Chartviewindia.in advised traders to avoid positional longs but should consider shorting rallies on early signs of weakness.

India VIX fell by 1.88 percent from 22.06 to 21.64 levels. VIX needs to cool down below 19 levels for market stability but volatility could spike ahead of US election, Chandan Taparia of Motilal Oswal said.

The Nifty50 opened higher at 11,727.40 and drifted lower to hit an intraday low of 11,667.85 in initial hour of trade, but immediately rebounded and stayed strong to touch a day's high of 11,789.75. The index settled at 11,762.50, up 82.10 points.

"It appears to be the day of consolidation on the bourses as Nifty remained in a range of 120 points before signing off the session with a small bullish candle which resembles an indecisive Spinning Top," Mazhar Mohammad, Chief Strategist – Technical Research & Trading Advisory at Chartviewindia.in told Moneycontrol.

However, "last Thursday's bigger cut appears to have catapulted the near term trend in favour of bears. Hence, rallies may not sustain but remain vulnerable for a sell off and as long as Nifty sustains above 11,661 levels then it can make an attempt to recoup some of the losses by rallying into the zone of 11,843 – 11,885 levels," he said.

If the index breaches 11,661, then it shall not only resume the downswing with initial targets present in the zone of 11,500 – 11,400 levels but also confirm a multi-week top around 12,025 levels, according to him.

On option front, maximum Put open interest was seen at 10,500 followed by 11,000 strike, while maximum Call open interest was at 12,500 followed by 12,000 strike. Call writing was seen at 11,700 then 12,100 strike while Put writing was seen at 11,700 then 11,500 strike.

The abovementioned option data suggested that an immediate trading range for Nifty could be 11,500 to 12,000 levels.

Bank Nifty opened higher at 23,219.85 and witnessed buying interest to hit an intraday high of 23,646.20 after taking support at 23,150-23,200 zones.

The index rallied 460.90 points or 2 percent to close at 23,533.30 and formed a bullish candle on daily scale, but a bearish candle on weekly which suggests a range bound bias in broader trading range. It lost 1.3 percent for the week.

"Now Bank Nifty has to hold above 23,500 to witness an upmove towards 23,750 and 24,000 while on the downside support exists at 23,150 then 23,000," Chandan Taparia, Vice President | Analyst-Derivatives at Motilal Oswal Financial Services said.

Positive setup was seen in JSW Steel, Tata Steel, Voltas, Hindalco, Divis Labs, SRF, Muthoot Finance, HDFC Bank, Grasim, ACC, UltraTech Cement, Ambuja Cements and Tata Chemicals while weakness was seen in UPL, Zee Entertainment, M&M, Reliance Industries, Sun Pharma and Vedanta, he added.


Comments

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...

Similar to 2020, D-Street is at record high ahead of Budget 2021; will history repeat itself?

  Experts are of the view that a repeat of 2020 or what happened in March might not be possible but some consolidation cannot be ruled out. Back in March when everyone wanted to write-off 2020 from their books, hope and liquidity supported markets and investor sentiment. Nobody thought that after touching a 3-year low in March 2020, benchmark indices would give double-digit returns by the end of the year. The S&P BSE Sensex and Nifty50 rallied by about 15 percent in 2020 and the big outperformance came from the small and midcap stocks. The rally is still continuing in 2021. The S&P BSE Sensex, which climbed Mount 49K, is up over 3 percent while the Nifty50 is up over 4 percent so far in January. Sensex scaling the 49,000-mark and Nifty50 touching 14,500 levels ahead of the Budget 2021 could make anyone cautious about the strength of the rally. Back in January 2020, both Sensex and Nifty touched fresh highs ahead of Budget, and then the market fell like a pack of cards. The ...